207 related articles for article (PubMed ID: 32563850)
1. Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity.
Mai Y; Guo J; Zhao Y; Ma S; Hou Y; Yang J
Cell Immunol; 2020 Aug; 354():104143. PubMed ID: 32563850
[TBL] [Abstract][Full Text] [Related]
2. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
Tada R; Hidaka A; Iwase N; Takahashi S; Yamakita Y; Iwata T; Muto S; Sato E; Takayama N; Honjo E; Kiyono H; Kunisawa J; Aramaki Y
PLoS One; 2015; 10(10):e0139785. PubMed ID: 26440657
[TBL] [Abstract][Full Text] [Related]
4. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
5. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
[TBL] [Abstract][Full Text] [Related]
6. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity.
Qu W; Li N; Yu R; Zuo W; Fu T; Fei W; Hou Y; Liu Y; Yang J
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):852-860. PubMed ID: 29447484
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3-IRF3 signaling and type I interferons in dendritic cells.
Wang C; Zhuang Y; Zhang Y; Luo Z; Gao N; Li P; Pan H; Cai L; Ma Y
Vaccine; 2012 Jul; 30(32):4790-9. PubMed ID: 22634298
[TBL] [Abstract][Full Text] [Related]
8. Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model.
Alipour Talesh G; Ebrahimi Z; Badiee A; Mansourian M; Attar H; Arabi L; Jalali SA; Jaafari MR
Immunol Lett; 2016 Aug; 176():57-64. PubMed ID: 27260485
[TBL] [Abstract][Full Text] [Related]
9. A simple but effective cancer vaccine consisting of an antigen and a cationic lipid.
Chen W; Yan W; Huang L
Cancer Immunol Immunother; 2008 Apr; 57(4):517-30. PubMed ID: 17724588
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine.
Yan W; Chen W; Huang L
J Control Release; 2008 Aug; 130(1):22-8. PubMed ID: 18554742
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.
Henriksen-Lacey M; Christensen D; Bramwell VW; Lindenstrøm T; Agger EM; Andersen P; Perrie Y
Mol Pharm; 2011 Feb; 8(1):153-61. PubMed ID: 21117621
[TBL] [Abstract][Full Text] [Related]
12. A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity.
Shen KY; Liu HY; Li HJ; Wu CC; Liou GG; Chang YC; Leng CH; Liu SJ
J Control Release; 2016 Jul; 233():57-63. PubMed ID: 27164542
[TBL] [Abstract][Full Text] [Related]
13. The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome.
Yan W; Huang L
Int J Pharm; 2009 Feb; 368(1-2):56-62. PubMed ID: 18992312
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects obtained by autologous Lewis lung cancer cell vaccine engineered to secrete mouse interleukin 27 by means of cationic liposome.
Zhang J; Tian H; Li C; Cheng L; Zhang S; Zhang X; Wang R; Xu F; Dai L; Shi G; Chen X; Li Y; Du T; Deng J; Liu Y; Yang Y; Wei Y; Deng H
Mol Immunol; 2013 Oct; 55(3-4):264-74. PubMed ID: 23522926
[TBL] [Abstract][Full Text] [Related]
15. Mannosylated protamine as a novel DNA vaccine carrier for effective induction of anti-tumor immune responses.
Zeng Z; Dai S; Jiao Y; Jiang L; Zhao Y; Wang B; Zong L
Int J Pharm; 2016 Jun; 506(1-2):394-406. PubMed ID: 27106528
[TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
[TBL] [Abstract][Full Text] [Related]
17. DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine.
Zhang R; Tang L; Tian Y; Ji X; Hu Q; Zhou B; Ding Z; Xu H; Yang L
J Control Release; 2020 Dec; 328():210-221. PubMed ID: 32860927
[TBL] [Abstract][Full Text] [Related]
18. Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN.
Mansourian M; Badiee A; Jalali SA; Shariat S; Yazdani M; Amin M; Jaafari MR
Immunol Lett; 2014 Nov; 162(1 Pt A):87-93. PubMed ID: 25086399
[TBL] [Abstract][Full Text] [Related]
19. Cationic lipid-assisted nanoparticles for delivery of mRNA cancer vaccine.
Fan YN; Li M; Luo YL; Chen Q; Wang L; Zhang HB; Shen S; Gu Z; Wang J
Biomater Sci; 2018 Nov; 6(11):3009-3018. PubMed ID: 30264063
[TBL] [Abstract][Full Text] [Related]
20. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
